HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blackstone Emerges As Likely Buyer For Takeda's OTC Business At Price Close To $3Bn

Executive Summary

Takeda's divestment long has been rumored and would take it to its oft-stated target of selling around $10bn in assets to pay down debt associated with its $62bn purchase of Shire that closed in January 2019.

You may also be interested in...



Nidda Investment Group Takes Full Ownership Of Stada Through Settlements With Shareholders

Nidda Healthcare, investment vehicle controlled by Bain Capital and Cinven, secured a “timely” squeeze-out of minority shareholders in Stada through settlement terms that include a one-time payment of 10 euro cents per outstanding share for the remaining shareholders.

Alnylam Secures $2bn Financing From Blackstone By Monetizing Inclisiran Royalties

Alnylam successfully completed a multi-pronged financing deal with the investment firm, which it will use to fund the development of more RNAi drugs.

Ferring And Blackstone Launch Gene Therapy Company

The Swiss group has decided to launch FerGene with the private equity giant to give the gene therapy nadofaragene firadenovec, which has a priority review at the FDA, a better chance for a successful launch in the US.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS150384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel